跳至主要内容
临床试验/IRCT20100524004010N34
IRCT20100524004010N34招募中2 期

The effects of caffeine supplementation on clinical parameters and disease severity in patients with hepatic cirrhosis

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 25 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Having desire to participate in the study
  • Age range of 18-75
  • BMI between 18.5 to 30 kg per square meter
  • Do not develop extrahepatic organ failure
  • Do not take caffeinated drugs for one month before the start of the study
  • Do not consume more than 3 cups of coffee per day
  • Not pregnant or breastfeeding

排除标准

  • The patient's unwillingness to continue cooperation
  • Patients who have consumed less than 80% of the capsules.
  • The diagnosis of the treating physician at the end of the patient's participation in the study
  • Pregnancy or breastfeeding
  • Loss of more than 10% of body weight during the study period

研究者

相似试验